Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are characterized by neuronal death within the brain and/or central nervous system (CNS), leading to progressive decline in functional neurological capacities. It has a devastating effect on quality of life and independence, often requiring full-time care during the later disease stages.
The Neurodegenerative Diseases is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period. The research provides insights for the global Neurodegenerative Diseases market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.
A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Neurodegenerative Diseases industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.
The Snapshot of Global Neurodegenerative Diseases Market Segmentations:
By Players:
Biogen Idec
Yangtze River Pharmaceutical Group
Alector
UCB
Merck Serono
HLundbeck A/S
Asubio Pharmaceutical
Chongqing Zein Pharmaceutical
Boehringer Ingelheim
Bial
Novartis
Yumanity Therapeutics
AstraZeneca
Jiangsu Hansoh Pharmaceutical
Amarin
Pfizer
Eisai
Addex Pharmaceutical
Bayer Schering Pharma AG
Teva Pharmaceutical
By Types:
NMDA
SSRIs
Dopamine Inhibitors
By End-User:
Parkinson’s disease
Huntington disease
Amyotrophic Lateral Sclerosis
Alzheimer’s disease
By Regions:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
France
-
Italy
-
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
-
Spain
-
Belgium
-
Poland
-
Russia
-
Turkey
-
Others
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia and New Zealand
-
ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)
Latin America, Middle East & Africa
-
GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
-
Brazil
-
Nigeria
-
South Africa
-
Argentina
-
Others
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Neurodegenerative Diseases Market
-
1.3 Market Segmentation by Type
-
1.3.1 Global Neurodegenerative Diseases Market Size and Growth Rate of NMDA from 2014 to 2026
-
1.3.2 Global Neurodegenerative Diseases Market Size and Growth Rate of SSRIs from 2014 to 2026
-
1.3.3 Global Neurodegenerative Diseases Market Size and Growth Rate of Dopamine Inhibitors from 2014 to 2026
-
1.4 Market Segmentation by End-Users
-
1.4.1 Global Neurodegenerative Diseases Market Size and Growth Rate of Parkinson’s disease from 2014 to 2026
-
1.4.2 Global Neurodegenerative Diseases Market Size and Growth Rate of Huntington disease from 2014 to 2026
-
1.4.3 Global Neurodegenerative Diseases Market Size and Growth Rate of Amyotrophic Lateral Sclerosis from 2014 to 2026
-
1.4.4 Global Neurodegenerative Diseases Market Size and Growth Rate of Alzheimer’s disease from 2014 to 2026
-
1.5 Market Segmentation by Regions
-
1.5.1 North America Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.1.1 United States Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.1.2 Canada Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.1.3 Mexico Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Europe Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.1 Germany Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.2 UK Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.3 France Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.4 Italy Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.5 Nordic Countries Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.6 Spain Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.7 Belgium Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.8 Poland Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.9 Russia Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.2.10 Turkey Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Asia-Pacific Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.1 China Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.2 Japan Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.3 Australia and New Zealand Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.4 India Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.5 ASEAN Countries Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.3.6 South Korea Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Latin America, Middle East & Africa Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4.1 GCC Countries Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4.2 Brazil Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4.3 Nigeria Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4.4 South Africa Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
-
1.5.4.5 Argentina Neurodegenerative Diseases Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Neurodegenerative Diseases Market by Types
-
3.1 Product Development Trends of Different Types
-
3.2 Commercial Product Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Neurodegenerative Diseases by Major Types
-
3.4.1 Neurodegenerative Diseases Market Size and Growth Rate of NMDA
-
3.4.2 Neurodegenerative Diseases Market Size and Growth Rate of SSRIs
-
3.4.3 Neurodegenerative Diseases Market Size and Growth Rate of Dopamine Inhibitors
4 Segmentation of Neurodegenerative Diseases Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Neurodegenerative Diseases by Major End-Users
-
4.4.1 Market Size and Growth Rate of Neurodegenerative Diseases in Parkinson’s disease
-
4.4.2 Market Size and Growth Rate of Neurodegenerative Diseases in Huntington disease
-
4.4.3 Market Size and Growth Rate of Neurodegenerative Diseases in Amyotrophic Lateral Sclerosis
-
4.4.4 Market Size and Growth Rate of Neurodegenerative Diseases in Alzheimer’s disease
5 Market Analysis by Major Regions
-
5.1 Global Neurodegenerative Diseases Production Analysis by Major Regions
-
5.2 Global Neurodegenerative Diseases Consumption Analysis by Major Regions
-
5.3 Global Neurodegenerative Diseases Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 North America Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
5.3.2 Europe Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
5.3.3 Asia Pacific Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
5.3.4 Latin America, Middle East & Africa Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
6 Product Commodity of Neurodegenerative Diseases Market in Major Countries
-
6.1 Top 5 Export Countries in Neurodegenerative Diseases market from 2014 to 2019
-
6.1.1 Top 5 Export Countries' Export Value Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
6.1.2 Top 5 Export Countries' Export Volume Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
6.2 Top 5 Import Countries in Neurodegenerative Diseases market from 2014 to 2019
-
6.2.1 Top 5 Import Countries' Import Value Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
6.2.2 Top 5 Import Countries' Import Volume Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7 North America Neurodegenerative Diseases Landscape Analysis
-
7.1 North America Neurodegenerative Diseases Landscape Analysis by Major Types
-
7.2 North America Neurodegenerative Diseases Landscape Analysis by Major End-Users
-
7.3 North America Neurodegenerative Diseases Landscape Analysis by Major Countries
-
7.3.1 United States Neurodegenerative Diseases Market Volume and Growth Rate
-
7.3.2 Canada Neurodegenerative Diseases Market Volume and Growth Rate
-
7.3.3 Mexico Neurodegenerative Diseases Market Volume and Growth Rate
8 Europe Neurodegenerative Diseases Landscape Analysis
-
8.1 Europe Neurodegenerative Diseases Landscape Analysis by Major Types
-
8.2 Europe Neurodegenerative Diseases Landscape Analysis by Major End-Users
-
8.3 Europe Neurodegenerative Diseases Landscape Analysis by Major Countries
-
8.3.1 Germany Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.2 UK Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.3 France Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.4 Italy Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.5 Nordic Countries Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.6 Spain Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.7 Belgium Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.8 Poland Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.9 Russia Neurodegenerative Diseases Market Volume and Growth Rate
-
8.3.10 Turkey Neurodegenerative Diseases Market Volume and Growth Rate
9 Asia Pacific Neurodegenerative Diseases Landscape Analysis
-
9.1 Asia Pacific Neurodegenerative Diseases Landscape Analysis by Major Types
-
9.2 Asia Pacific Neurodegenerative Diseases Landscape Analysis by Major End-Users
-
9.3 Asia Pacific Neurodegenerative Diseases Landscape Analysis by Major Countries
-
9.3.1 China Neurodegenerative Diseases Market Volume and Growth Rate
-
9.3.2 Japan Neurodegenerative Diseases Market Volume and Growth Rate
-
9.3.3 Australia and New Zealand Neurodegenerative Diseases Market Volume and Growth Rate
-
9.3.4 India Neurodegenerative Diseases Market Volume and Growth Rate
-
9.3.5 ASEAN Countries Neurodegenerative Diseases Market Volume and Growth Rate
-
9.3.6 South Korea Neurodegenerative Diseases Market Volume and Growth Rate
10 Latin America, Middle East & Africa Neurodegenerative Diseases Landscape Analysis
-
10.1 Latin America, Middle East & Africa Neurodegenerative Diseases Landscape Analysis by Major Types
-
10.2 Latin America, Middle East & Africa Neurodegenerative Diseases Landscape Analysis by Major End-Users
-
10.3 Latin America, Middle East & Africa Neurodegenerative Diseases Landscape Analysis by Major Countries
-
10.3.1 GCC Countries Neurodegenerative Diseases Market Volume and Growth Rate
-
10.3.2 Brazil Neurodegenerative Diseases Market Volume and Growth Rate
-
10.3.3 Nigeria Neurodegenerative Diseases Market Volume and Growth Rate
-
10.3.4 South Africa Neurodegenerative Diseases Market Volume and Growth Rate
-
10.3.5 Argentina Neurodegenerative Diseases Market Volume and Growth Rate
11 Major Players Profile
-
11.1 Biogen Idec
-
11.1.1 Biogen Idec Company Profile and Recent Development
-
11.1.2 Market Performance
-
11.1.3 Product and Service Introduction
-
11.2 Yangtze River Pharmaceutical Group
-
11.2.1 Yangtze River Pharmaceutical Group Company Profile and Recent Development
-
11.2.2 Market Performance
-
11.2.3 Product and Service Introduction
-
11.3 Alector
-
11.3.1 Alector Company Profile and Recent Development
-
11.3.2 Market Performance
-
11.3.3 Product and Service Introduction
-
11.4 UCB
-
11.4.1 UCB Company Profile and Recent Development
-
11.4.2 Market Performance
-
11.4.3 Product and Service Introduction
-
11.5 Merck Serono
-
11.5.1 Merck Serono Company Profile and Recent Development
-
11.5.2 Market Performance
-
11.5.3 Product and Service Introduction
-
11.6 HLundbeck A/S
-
11.6.1 HLundbeck A/S Company Profile and Recent Development
-
11.6.2 Market Performance
-
11.6.3 Product and Service Introduction
-
11.7 Asubio Pharmaceutical
-
11.7.1 Asubio Pharmaceutical Company Profile and Recent Development
-
11.7.2 Market Performance
-
11.7.3 Product and Service Introduction
-
11.8 Chongqing Zein Pharmaceutical
-
11.8.1 Chongqing Zein Pharmaceutical Company Profile and Recent Development
-
11.8.2 Market Performance
-
11.8.3 Product and Service Introduction
-
11.9 Boehringer Ingelheim
-
11.9.1 Boehringer Ingelheim Company Profile and Recent Development
-
11.9.2 Market Performance
-
11.9.3 Product and Service Introduction
-
11.10 Bial
-
11.10.1 Bial Company Profile and Recent Development
-
11.10.2 Market Performance
-
11.10.3 Product and Service Introduction
-
11.11 Novartis
-
11.11.1 Novartis Company Profile and Recent Development
-
11.11.2 Market Performance
-
11.11.3 Product and Service Introduction
-
11.12 Yumanity Therapeutics
-
11.12.1 Yumanity Therapeutics Company Profile and Recent Development
-
11.12.2 Market Performance
-
11.12.3 Product and Service Introduction
-
11.13 AstraZeneca
-
11.13.1 AstraZeneca Company Profile and Recent Development
-
11.13.2 Market Performance
-
11.13.3 Product and Service Introduction
-
11.14 Jiangsu Hansoh Pharmaceutical
-
11.14.1 Jiangsu Hansoh Pharmaceutical Company Profile and Recent Development
-
11.14.2 Market Performance
-
11.14.3 Product and Service Introduction
-
11.15 Amarin
-
11.15.1 Amarin Company Profile and Recent Development
-
11.15.2 Market Performance
-
11.15.3 Product and Service Introduction
-
11.16 Pfizer
-
11.16.1 Pfizer Company Profile and Recent Development
-
11.16.2 Market Performance
-
11.16.3 Product and Service Introduction
-
11.17 Eisai
-
11.17.1 Eisai Company Profile and Recent Development
-
11.17.2 Market Performance
-
11.17.3 Product and Service Introduction
-
11.18 Addex Pharmaceutical
-
11.18.1 Addex Pharmaceutical Company Profile and Recent Development
-
11.18.2 Market Performance
-
11.18.3 Product and Service Introduction
-
11.19 Bayer Schering Pharma AG
-
11.19.1 Bayer Schering Pharma AG Company Profile and Recent Development
-
11.19.2 Market Performance
-
11.19.3 Product and Service Introduction
-
11.20 Teva Pharmaceutical
-
11.20.1 Teva Pharmaceutical Company Profile and Recent Development
-
11.20.2 Market Performance
-
11.20.3 Product and Service Introduction
12 Data Source and Research Methodology
The List of Tables and Figures (Totals 89 Figures and 137 Tables)
-
Figure Product Picture
-
Figure Neurodegenerative Diseases Market Size and Growth Rate of NMDA from 2014 to 2026
-
Figure Neurodegenerative Diseases Market Size and Growth Rate of SSRIs from 2014 to 2026
-
Figure Neurodegenerative Diseases Market Size and Growth Rate of Dopamine Inhibitors from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
-
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Parkinson’s disease from 2014 to 2026
-
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Huntington disease from 2014 to 2026
-
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Amyotrophic Lateral Sclerosis from 2014 to 2026
-
Figure Global Neurodegenerative Diseases Market Size and Growth Rate of Alzheimer’s disease from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure North America Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure United States Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Canada Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Mexico Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Europe Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Germany Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure UK Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure France Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Italy Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Spain Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Belgium Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Poland Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Russia Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Turkey Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Asia-Pacific Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure China Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Japan Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Australia and New Zealand Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure India Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Korea Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure GCC Countries Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Brazil Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Nigeria Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure South Africa Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Argentina Neurodegenerative Diseases Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Neurodegenerative Diseases Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Neurodegenerative Diseases
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Neurodegenerative Diseases by Different Types from 2014 to 2026
-
Table Consumption Share of Neurodegenerative Diseases by Different Types from 2014 to 2026
-
Figure Market Size and Growth Rate of NMDA
-
Figure Market Size and Growth Rate of SSRIs
-
Figure Market Size and Growth Rate of Dopamine Inhibitors
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Neurodegenerative Diseases by Different End-Users from 2014 to 2026
-
Table Consumption Share of Neurodegenerative Diseases by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Parkinson’s disease
-
Figure Market Size and Growth Rate of Huntington disease
-
Figure Market Size and Growth Rate of Amyotrophic Lateral Sclerosis
-
Figure Market Size and Growth Rate of Alzheimer’s disease
-
Table Global Neurodegenerative Diseases Production by Major Regions
-
Table Global Neurodegenerative Diseases Production Share by Major Regions
-
Figure Global Neurodegenerative Diseases Production Share by Major Regions in 2014
-
Figure Global Neurodegenerative Diseases Production Share by Major Regions in 2018
-
Figure Global Neurodegenerative Diseases Production Share by Major Regions in 2026
-
Table Global Neurodegenerative Diseases Consumption by Major Regions
-
Table Global Neurodegenerative Diseases Consumption Share by Major Regions
-
Figure Global Neurodegenerative Diseases Consumption Share by Major Regions in 2014
-
Figure Global Neurodegenerative Diseases Consumption Share by Major Regions in 2018
-
Figure Global Neurodegenerative Diseases Consumption Share by Major Regions in 2026
-
Table North America Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
Table Europe Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
Table Asia Pacific Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
Table Top 5 Export Countries' Export Volume Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
Table Top 5 Import Countries' Import Value Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
Table Top 5 Import Countries' Import Volume Analysis in Neurodegenerative Diseases market from 2014 to 2019
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table North America Neurodegenerative Diseases Consumption by Types from 2014 to 2026
-
Table North America Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026
-
Figure North America Neurodegenerative Diseases Consumption Share by Types in 2014
-
Figure North America Neurodegenerative Diseases Consumption Share by Types in 2018
-
Figure North America Neurodegenerative Diseases Consumption Share by Types in 2026
-
Table North America Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026
-
Table North America Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026
-
Figure North America Neurodegenerative Diseases Consumption Share by End-Users in 2014
-
Figure North America Neurodegenerative Diseases Consumption Share by End-Users in 2018
-
Figure North America Neurodegenerative Diseases Consumption Share by End-Users in 2026
-
Table North America Neurodegenerative Diseases Consumption by Major Countries from 2014 to 2026
-
Table North America Neurodegenerative Diseases Consumption Share by Major Countries from 2014 to 2026
-
Figure North America Neurodegenerative Diseases Consumption Share by Major Countries in 2014
-
Figure North America Neurodegenerative Diseases Consumption Share by Major Countries in 2018
-
Figure North America Neurodegenerative Diseases Consumption Share by Major Countries in 2026
-
Figure United States Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Canada Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Mexico Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Table Europe Neurodegenerative Diseases Consumption by Types from 2014 to 2026
-
Table Europe Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026
-
Figure Europe Neurodegenerative Diseases Consumption Share by Types in 2014
-
Figure Europe Neurodegenerative Diseases Consumption Share by Types in 2018
-
Figure Europe Neurodegenerative Diseases Consumption Share by Types in 2026
-
Table Europe Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026
-
Table Europe Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026
-
Figure Europe Neurodegenerative Diseases Consumption Share by End-Users in 2014
-
Figure Europe Neurodegenerative Diseases Consumption Share by End-Users in 2018
-
Figure Europe Neurodegenerative Diseases Consumption Share by End-Users in 2026
-
Table Europe Neurodegenerative Diseases Consumption by Major Countries from 2014 to 2026
-
Table Europe Neurodegenerative Diseases Consumption Share by Major Countries from 2014 to 2026
-
Figure Europe Neurodegenerative Diseases Consumption Share by Major Countries in 2014
-
Figure Europe Neurodegenerative Diseases Consumption Share by Major Countries in 2018
-
Figure Europe Neurodegenerative Diseases Consumption Share by Major Countries in 2026
-
Figure Germany Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure UK Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure France Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Italy Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Nordic Countries Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Belgium Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Poland Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Russia Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Turkey Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption by Types from 2014 to 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Types in 2014
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Types in 2018
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Types in 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by End-Users in 2014
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by End-Users in 2018
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by End-Users in 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption by Major Countries from 2014 to 2026
-
Table Asia Pacific Neurodegenerative Diseases Consumption Share by Major Countries from 2014 to 2026
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Major Countries in 2014
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Major Countries in 2018
-
Figure Asia Pacific Neurodegenerative Diseases Consumption Share by Major Countries in 2026
-
Figure China Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Japan Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Australia and New ZealandNeurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure India Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure ASEAN Countries Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure South Korea Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption by Types from 2014 to 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Types from 2014 to 2026
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Types in 2014
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Types in 2018
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Types in 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption by End-Users from 2014 to 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by End-Users from 2014 to 2026
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by End-Users in 2014
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by End-Users in 2018
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by End-Users in 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption by Major Countries from 2014 to 2026
-
Table Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Major Countries from 2014 to 2026
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Major Countries in 2014
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Major Countries in 2018
-
Figure Latin America, Middle East & Africa Neurodegenerative Diseases Consumption Share by Major Countries in 2026
-
Figure GCC Countries Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Brazil Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Nigeria Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure South Africa Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Figure Argentina Neurodegenerative Diseases Market Volume and Growth Rate from 2014 to 2026
-
Table Company Profile and Development Status of Biogen Idec
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen Idec
-
Figure Sales and Growth Rate Analysis of Biogen Idec
-
Figure Revenue and Market Share Analysis of Biogen Idec
-
Table Product and Service Introduction of Biogen Idec
-
Table Company Profile and Development Status of Yangtze River Pharmaceutical Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yangtze River Pharmaceutical Group
-
Figure Sales and Growth Rate Analysis of Yangtze River Pharmaceutical Group
-
Figure Revenue and Market Share Analysis of Yangtze River Pharmaceutical Group
-
Table Product and Service Introduction of Yangtze River Pharmaceutical Group
-
Table Company Profile and Development Status of Alector
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alector
-
Figure Sales and Growth Rate Analysis of Alector
-
Figure Revenue and Market Share Analysis of Alector
-
Table Product and Service Introduction of Alector
-
Table Company Profile and Development Status of UCB
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB
-
Figure Sales and Growth Rate Analysis of UCB
-
Figure Revenue and Market Share Analysis of UCB
-
Table Product and Service Introduction of UCB
-
Table Company Profile and Development Status of Merck Serono
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Serono
-
Figure Sales and Growth Rate Analysis of Merck Serono
-
Figure Revenue and Market Share Analysis of Merck Serono
-
Table Product and Service Introduction of Merck Serono
-
Table Company Profile and Development Status of HLundbeck A/S
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of HLundbeck A/S
-
Figure Sales and Growth Rate Analysis of HLundbeck A/S
-
Figure Revenue and Market Share Analysis of HLundbeck A/S
-
Table Product and Service Introduction of HLundbeck A/S
-
Table Company Profile and Development Status of Asubio Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Asubio Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Asubio Pharmaceutical
-
Figure Revenue and Market Share Analysis of Asubio Pharmaceutical
-
Table Product and Service Introduction of Asubio Pharmaceutical
-
Table Company Profile and Development Status of Chongqing Zein Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chongqing Zein Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Chongqing Zein Pharmaceutical
-
Figure Revenue and Market Share Analysis of Chongqing Zein Pharmaceutical
-
Table Product and Service Introduction of Chongqing Zein Pharmaceutical
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
Table Company Profile and Development Status of Bial
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bial
-
Figure Sales and Growth Rate Analysis of Bial
-
Figure Revenue and Market Share Analysis of Bial
-
Table Product and Service Introduction of Bial
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Yumanity Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yumanity Therapeutics
-
Figure Sales and Growth Rate Analysis of Yumanity Therapeutics
-
Figure Revenue and Market Share Analysis of Yumanity Therapeutics
-
Table Product and Service Introduction of Yumanity Therapeutics
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Jiangsu Hansoh Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jiangsu Hansoh Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Jiangsu Hansoh Pharmaceutical
-
Figure Revenue and Market Share Analysis of Jiangsu Hansoh Pharmaceutical
-
Table Product and Service Introduction of Jiangsu Hansoh Pharmaceutical
-
Table Company Profile and Development Status of Amarin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amarin
-
Figure Sales and Growth Rate Analysis of Amarin
-
Figure Revenue and Market Share Analysis of Amarin
-
Table Product and Service Introduction of Amarin
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Eisai
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai
-
Figure Sales and Growth Rate Analysis of Eisai
-
Figure Revenue and Market Share Analysis of Eisai
-
Table Product and Service Introduction of Eisai
-
Table Company Profile and Development Status of Addex Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addex Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Addex Pharmaceutical
-
Figure Revenue and Market Share Analysis of Addex Pharmaceutical
-
Table Product and Service Introduction of Addex Pharmaceutical
-
Table Company Profile and Development Status of Bayer Schering Pharma AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer Schering Pharma AG
-
Figure Sales and Growth Rate Analysis of Bayer Schering Pharma AG
-
Figure Revenue and Market Share Analysis of Bayer Schering Pharma AG
-
Table Product and Service Introduction of Bayer Schering Pharma AG
-
Table Company Profile and Development Status of Teva Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical
-
Table Product and Service Introduction of Teva Pharmaceutical
-
